July 15, 2021 6:08 pm Published by admin Taking Charge of Your Care Virtual Dialogue 3 September 14, 7:30PM -9:00PM EST Via Zoom Registration: https://csfshayna.org/virtual-dialogue3-registration/ Chondrosarcoma Survivors and Sarcoma Providers will discuss how you can make informed decisions to take charge of your care. One of the five presentors is Mike Snyder. Mike Snyder lives in Albuquerque, New Mexico with his wife, Sarah. [...]
July 15, 2021 5:53 pm Published by admin [...]
July 12, 2021 8:56 pm Published by admin Chondrosarcoma CS Foundation, Inc. Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) Join Us for This Very Informative Event: Click here to Register The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual [...]
July 5, 2021 12:47 am Published by admin This #SarcomaAwareness Month, please help raise awareness of the symptoms of bone sarcoma by liking and sharing our graphic below. Symptoms of bone sarcoma / primary bone cancer can be very general and often appear similar to the symptoms of sports injuries, growing pains or many other common conditions such as tendonitis or arthritis. If [...]
July 2, 2021 7:29 pm Published by admin Listed below is a message sent by my late daughter Shayna two years ago (July 2, 2019) to promote Sarcoma Awareness Month. Yesterday was the first day of Sarcoma Awareness Month. As someone that is currently fighting a sarcoma I can say that my life has change so much since I was first diagnosed in [...]
June 27, 2021 3:05 am Published by admin Published: Jun 21, 2021 SAN DIEGO, June 21, 2021 /PRNewswire/ — InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced initiation of a potential registration-enabling Phase 2 study of INBRX-109 in conventional chondrosarcoma. Inhibrx, Inc. logo (PRNewsfoto/Inhibrx, Inc.) INBRX-109 is a precision-engineered, tetravalent death receptor 5 (DR5) agonist antibody designed [...]
June 19, 2021 5:13 pm Published by admin SUMMARY This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in treating patients with conventional chondrosarcoma that cannot be removed by surgery (unresectable) and has spread to other places in the body (metastatic). Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell [...]
June 3, 2021 1:38 am Published by admin Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health. The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer Center (mskcc.org) Transcript: Barbra Rothschild: Hello, everybody. Welcome to the special information session hosted by MSK’s Patient and Family Advisory Council for Quality in collaboration [...]
May 26, 2021 6:01 pm Published by admin Targeted Cancer Therapies ON THIS PAGE What are targeted cancer therapies? How are targets for targeted cancer therapies identified? How are targeted therapies developed? What types of targeted therapies are available? How is it determined whether a patient is a candidate for targeted therapy? What are the limitations of targeted cancer therapies? What are the [...]
May 25, 2021 2:05 am Published by admin Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health. The link is listed below as well as the transcript. The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer Center (mskcc.org) Transcript: Barbra Rothschild: Hello, everybody. Welcome to the special information session hosted by [...]
